April 14 (Reuters) - Longevity Health Holdings Inc XAGE.O:
LONGEVITY HEALTH HOLDINGS ANNOUNCES EXECUTION OF MERGER AGREEMENT WITH 20/20 BIOLABS
LONGEVITY HEALTH HOLDINGS INC - COMBINED COMPANY TO TRADE ON NASDAQ UNDER SYMBOL 'XAGE'
LONGEVITY HEALTH HOLDINGS INC - POST-CLOSING EQUITY VALUATION OF COMBINED CO EXPECTED TO BE $99 MILLION
LONGEVITY HEALTH HOLDINGS INC - MERGER EXPECTED TO DOUBLE LONGEVITY'S FY 2025 REVENUE TO $7-8 MILLION
LONGEVITY HEALTH HOLDINGS INC - RAJIV SHUKLA TO REMAIN CHAIRMAN, JONATHAN COHEN TO BE APPOINTED CEO
LONGEVITY HEALTH HOLDINGS INC - MERGER EXPECTED TO CLOSE IN Q3 2025
LONGEVITY HEALTH HOLDINGS INC - 20/20 PRE-MERGER STOCKHOLDERS TO OWN 50.1% OF COMBINED COMPANY POST-MERGER
Source text: ID:nGNXccSBlb
Further company coverage: XAGE.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.